Can magnesium enhance blood coagulation amongst patients with alcohol induced liver cirrhosis?

Can magnesium enhance blood coagulation amongst patients with alcohol induced liver cirrhosis? - MG001

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2012-005454-35-FI

Enrollment

Registered

2013-02-19

Start date

2013-03-13

Completion date

Unknown

Last updated

2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver transplant candidates with alcohol induced liver cirrhosis and hypomagnesemia (P-Mg under 0,71 or magnesium substitution at least 750 mg/day) MedDRA version: 14.1 Level: LLT Classification code 10024667 Term: Liver cirrhosis System Organ Class: 100000004871

Interventions

Trade Name: Addex-Magnesium sulfate 246 mg/ml infusion concentrate for solution Product Name: Addex-Magnesium sulfate 246 mg/ml infusion concentrate for solution Pharmaceutical Form: Concentrate for s

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Age between 18-70 years Liver transplant candidate Alcohol induced liver cirrhosis Hypomagnesemia (P-Mg below 0,71 or magnesium substitution at least 750 mg/vrk) Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 15 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 5

Exclusion criteria

Exclusion criteria: Age under 18 years or over 70 years Non alcohol induced liver cirrhosis Normal magnesium plasma levels without magnesium substitution Magnesium substitution under 750 mg/day

Design outcomes

Primary

Measure	Time frame
Main Objective: To find out if by giving magnesium it would be possible to enhance blood coagulation tendencies amongst patients with alcohol induced liver cirrhosis;Secondary Objective: Not applicable;Primary end point(s):	—

Countries

Finland

Contacts

Public ContactBiomedicum 1 / room B418a

Hanna Pitkänen

hanna.h.pitkanen@fimnet.fi

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026